CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 20 target
Drug / intervention
Endovascular autologous mitochondrial transplantationother
Likely dose
Not stated in record
Key inclusion· 3
  • Eligible for endovascular thrombectomy to treat acute large vessel occlusion
  • Eligible for angioplasty to treat acute cerebral vasospasm after aneurysmal subarachnoid hemorrhage
  • Sufficient time to obtain meaningful consent from patient or legally-authorized representative
Key exclusion· 3
  • Unable to receive a brain MRI scan
  • Known mitochondrial disease
  • Hemodynamically unstable patients in whom standard of care endovascular reperfusion treatment cannot safely be performed or completed

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04998357
NCT04998357N/ARecruitingMonitorUpdated 13mo ago · Completion was 2mo ago
Slow Enrollment
Long Recruiting
Monitor

Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia

University of Washington·interventional·Posted Aug 10, 2021·Updated May 21, 2025

In Brief

A clinical study evaluating Endovascular autologous mitochondrial transplantation for Cerebral Ischemia. Currently recruiting, targeting 20 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ARecruiting
20222023202420252026
First PostedAug 10, 2021
Enrollment StartApr 29, 2021
Primary CompletionApr 29, 2026
Study CompletionOct 29, 2026
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 4.9 years ago

Interventions

Endovascular autologous mitochondrial transplantationother

During standard-of-care endovascular reperfusion procedure, subjects will have autologous mitochondria infused via microcatheter into ischemic brain.